Global COPD Drugs Market Forecast to 2023 COPD Market Report | Page 20

List of Figures
Figure No.
Figure Title
Market, By Value, 2018-2023(USD Million)
Page No.
Figure 161: China COPD Drugs Figure 162: China, Smoking Prevalence, Age 15+, % of Total Population, 2012-2016 144
Figure 163: China, Tobacco Attributable Deaths, 2030 144
Figure 164: China, PM2.5 air pollution, mean annual exposure (micrograms per cubic meter), 2012-2016 144
Figure 165: Beijing annual PM2.5 air pollution levels, 2013-2017, ( in micrograms per cubic meter of air) 145
Figure 166: China Co2 Emissions, 2013-2016 (Billion Metric Tons) 145
Figure 167: China, Population Above 65 (% of Total), 2013-2017 145
Figure 168: China, GDP Growth Per Year, 2015-2019 (In %) 146
Figure 169: China, Share of Urban Population, 2012-2017 (In %) 146
Figure 170: China, Total Population, 2013-2021F (In Billion) 146
Figure 171: China COPD Drugs Market Size, By Drug Type, 2017 (%) 147
Figure 172: China COPD Drugs 147
Figure 173: China COPD Drugs Market, By Drug Type, By Value, 2013-2017 (USD Million) 148
Figure 174: Japan COPD Drugs Market, By Value, 2013-2017 (USD Million) 150
Figure 175: Japan COPD Drugs Market, By Value, 2018-2023(USD Million) 150
Figure 176: Japan, Population ages 65 and above, 2012-2017 (% of total) 151
Figure 177: Japan, Smoking Prevalence, Age 15+, 2012-2016, (% of Total Prevalence) 152
Figure 178: Japan, Medical Facilities Outlook 152
Figure 179: Japan Healthcare Expenditure Outlook (%) 152
Figure 180: Japan, PM2.5 air pollution, mean annual exposure (micrograms per cubic meter), 2012-2016 153
Market Size, By Drug Type, 2023F (%)
(c) AZOTH Analytics
142
20